MDMA reimbursement advisory counsel
This article was originally published in The Gray Sheet
Executive Summary
Kathy Means, formerly senior public policy advisor for law firm Patton Boggs, joins the trade association to advise on reimbursement issues. Means takes over for Dan Waldmann, who joined J&J as director of federal affairs & reimbursement for medical devices June 2 (1"The Gray Sheet" May 19, 2003, In Brief)...
You may also be interested in...
MDMA consultant Kathy Means
Consultant on reimbursement issues remains at Patton Boggs. "The Gray Sheet" characterized Means as a former senior public policy advisor for the Washington, D.C. law firm (1"The Gray Sheet" June 9, 2003, In Brief)...
J&J’s D.C. reimbursement office
Daniel Waldmann of The Waldmann Group, consultant to St. Jude Medical and the Medical Device Manufacturers Association, becomes Johnson & Johnson director of federal affairs & reimbursement for medical devices June 2, overseeing the Cypher sirolimus-eluting stent and iBOT stair-climbing wheelchair. He joins Health Policy Director Greg White in J&J's Washington, D.C. office...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.